AN

Amar Nath Gagneja

Director Director DIN 08187928
DIN 08187928 First appointment Jul 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2018
Shareholding value Locked Premium profile

About Amar Nath Gagneja

Amar Nath Gagneja has 8 years in corporate governance. Formerly with 1 company, such as Icines Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08187928
Primary Designation Director
First Appointment 27 Jul 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 27 Jul 2018 2018 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Icines Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amar Nath Gagneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amar Nath Gagneja

Amar Nath Gagneja has 8 years in corporate governance. Formerly with 1 company, such as Icines Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Amar Nath Gagneja is associated with 0 companies as a director.

Amar Nath Gagneja has expertise in General Business.

Amar Nath Gagneja has 8 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available